Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00508638 · ClinicalTrials.gov registry record
Identifying High- and Low-Risk Heart Failure Patients in the Emergency Department (The Stratify Study)
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 1,033
- Enrollment target
NCT00508638: Completed study, sponsored by Vanderbilt University.
NCT00508638 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 1,033 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00508638 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 1,033 participants
- Enrollment target
Study Summary
People with heart failure (HF) symptoms who are seen in the emergency department (ED) are often admitted to the hospital even though it may not be necessary. This study will gather information from HF patients seen in the ED to develop a decision-making tool that will help doctors predict the risk of HF-related death or serious complications. Improving the ability of ED doctors to effectively and safely manage low-risk HF patients should lead to fewer unnecessary hospitalizations.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,033 participants |
| Start Date | 2007-05 |
| Est. Completion | 2015-12 |
What the finished NCT00508638 record still lists
NCT00508638 is an observational study that tracks outcomes without assigning an intervention. Its 1,033 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00508638 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00508638 about?
NCT00508638 is a clinical study titled "Identifying High- and Low-Risk Heart Failure Patients in the Emergency Department (The Stratify Study)". People with heart failure (HF) symptoms who are seen in the emergency department (ED) are often admitted to the hospital even though it may not be necessary. This study will gather information from HF patients seen in the ED to develop a decision-making tool that will help doctors predict the risk o...
What is the current status of trial NCT00508638?
This trial is currently completed. The enrollment target is 1,033 participants. The study started on 2007-05. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT00508638?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07084363 · 1,032 participants · NA
Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery
- NCT05037682 · 1,035 participants · NA
Pain and Opioid Management in Older Adults
- NCT07282600 · 1,035 participants · Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- NCT06080698 · 1,030 participants · NA
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia